For sales

Highlights from the Week of 20th April – 27th April in the world of pharma and healthcare! 

Highlights from the Week of 20th April - 27th April FDA approves Sanofi's TZIELD sBLA to delay the onset of stage 3 type 1 diabetes in young children AstraZeneca's SAPHNELO Pen for self-administration gets FDA approval for the treatment of adult patients with SLE on top of standard therapy Regeneron receives accelerated approval from FDA for OTARMENI to treat patients with severe-to-profound and profound sensorineural hearing loss ( FDA, Accelerated Approval ) ( FDA, Approval ) ( FDA, Approval ) Pg 1/6 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.